comorbid conditions

Related by string. * Comorbid : comorbid psychiatric disorders . comorbid depression . comorbid disorders . comorbid psychiatric . comorbid anxiety . comorbid substance / Conditions . conditioned . Condition . conditioning . conditioner . Conditioning : customary closing conditions . Pre Existing Condition . conditioned upon . air conditioner . Critical Condition After . air conditioning * *

Related by context. All words. (Click for frequent words.) 82 comorbidities 76 co morbidities 74 comorbidity 74 psychiatric comorbidities 70 comorbid 70 sociodemographic factors 69 LUTS 69 perioperative complications 69 lipid lowering agents 69 morbidities 69 depressive symptomatology 68 nonadherence 67 psychiatric comorbidity 67 macrovascular disease 67 postoperative AF 67 comorbid psychiatric 67 comorbid disorders 67 T2DM 67 TEAEs 67 comorbid illnesses 67 sociodemographic characteristics 67 β blockers 67 androgen deficiency 66 covariate 66 subclinical hypothyroidism 66 hypertension diabetes mellitus 66 postoperative complication 66 HRQL 66 NNT = 66 confounding variables 66 extrapyramidal symptoms 66 autonomic dysfunction 66 fragility fracture 66 comorbid depression 65 IPAH 65 coexisting illnesses 65 hypoglycemic events 65 noncardiac 65 affective psychoses 65 chronicity 65 carotid stenosis 65 thromboembolic 65 nondiabetic patients 65 systolic hypertension 65 HRQOL 65 neurologic complications 65 neovascular glaucoma 65 advanced neoplasia 65 multivariate analyzes 64 macrovascular events 64 postoperative morbidity 64 antiplatelet medications 64 postoperative infections 64 renal dysfunction 64 coronary revascularization procedures 64 obstetric complications 64 renal artery stenosis 64 covariates 64 nonoperative treatment 64 OAB symptoms 64 prostate cancer CaP 64 noncardiovascular mortality 64 carotid IMT 64 oncologic outcomes 64 CVD mortality 64 atherogenic dyslipidemia 64 revascularization procedures 64 LV dysfunction 64 renal impairment 64 adenoidectomy 64 Complication rates 64 prognostic variables 64 thromboprophylaxis 64 obstructive CAD 64 lipid parameters 64 postoperative mortality 64 elevated LDH 63 somatic symptoms 63 renal insufficiency 63 venous thromboembolic disease 63 HIV HCV coinfected 63 coronary revascularization 63 psychiatric morbidity 63 ALT flares 63 EDSS scores 63 nonvertebral fractures 63 Sleep disordered breathing 63 thromboembolic events 63 antidiabetic medications 63 Comorbid 63 microvascular disease 63 hyperbilirubinemia 63 MetS 63 androgen deprivation 63 NIHSS score 63 oxygen desaturation 63 overactive bladder symptoms 63 recurrent tonsillitis 63 cardiovascular comorbidities 63 perioperative morbidity 63 perioperative mortality 63 thyrotropin levels 63 loop diuretics 63 underdiagnosis 63 beta blocker therapy 63 abdominal adiposity 63 hypoglycemic episodes 63 warfarin therapy 63 dyslipidaemia 63 generalized tonic clonic seizures 63 postdischarge 63 nonfatal MI 63 elevated IOP 63 tumor histology 63 asthma exacerbations 63 adenotonsillectomy 63 pathologic fractures 63 neurocognitive impairment 63 acetabular dysplasia 63 subthreshold depression 63 somatoform disorders 63 aldosterone antagonist 63 neurocognitive deficits 63 atherothrombotic 63 adenomatous polyps 63 metabolic abnormalities 63 prognostic factors 62 HbA1c levels 62 morbidity mortality 62 subtrochanteric 62 potential confounders 62 cerebral microbleeds 62 thromboembolism 62 MMSE score 62 atrophic gastritis 62 postoperative atrial fibrillation 62 postoperative delirium 62 OSAHS 62 neuropsychiatric symptoms 62 logistic regression model 62 microalbuminuria 62 radical prostatectomy RP 62 HbA1C levels 62 GnRH agonists 62 Heavy menstrual bleeding 62 nontraumatic 62 paroxysmal AF 62 subgroup analyzes 62 hypoxemia 62 analgesic medications 62 stable angina 62 poststroke 62 left ventricular dysfunction 62 UA NSTEMI 62 lipid lowering medications 62 overt nephropathy 62 severe hypoglycemia 62 periprocedural 62 Subgroup analyzes 62 antiarrhythmic drug 62 variceal bleeding 62 Charlson comorbidity index 62 oral anticoagulation 62 preoperative diagnosis 62 ß blockers 62 recurrent ischemia 62 confounders 62 glucocorticoid therapy 62 CLBP 62 nonpharmacologic 62 thrombophilia 62 NATRECOR ® 62 glycated hemoglobin levels 62 biochemical recurrence 62 pharmacologic treatments 62 microbleeds 62 TNF antagonist 62 antidiabetic drugs 62 Cognitive impairment 62 hyperglycaemia 62 sociodemographic 62 nonvertebral fracture 62 HRQoL 62 Excessive daytime sleepiness 62 venlafaxine Effexor 62 syndromal 62 GERD symptoms 62 atherothrombosis 62 COPD exacerbation 62 antihypertensive medications 62 intracerebral haemorrhage 62 thromboembolic complications 62 ICD therapy 62 neurological abnormalities 62 adverse cytogenetics 62 anticonvulsant medications 62 urinary symptoms 62 T1DM 62 PONV 61 lipid lowering therapy 61 impaired cognition 61 paroxetine Paxil 61 adrenal insufficiency 61 multivariable analyzes 61 preoperative PSA 61 amenorrhoea 61 HbA 1c levels 61 POAG 61 subclinical atherosclerosis 61 syndromic 61 mild renal insufficiency 61 nondepressed 61 poor metabolizers 61 antimicrobial prophylaxis 61 typical antipsychotics 61 neurodevelopmental impairment 61 % CI #.#-#.# [006] 61 Erythropoietic therapies may 61 medication nonadherence 61 upper gastrointestinal bleeding 61 bowel resection 61 carotid plaques 61 Atypical antipsychotics 61 alexithymia 61 Exclusion criteria 61 intraoperative complications 61 oral hypoglycemic agents 61 concomitant medications 61 lower extremity amputation 61 Comorbidities 61 Venous thromboembolism 61 carotid intima media 61 haematologic 61 undergoing radical prostatectomy 61 primary aldosteronism 61 MMSE scores 61 neurologic sequelae 61 stratifying patients 61 coronary stenosis 61 anticoagulation therapy 61 serum creatinine levels 61 comorbid diagnoses 61 sociodemographic variables 61 post thrombotic syndrome 61 antibiotic prophylaxis 61 hemorrhagic complications 61 acetabular fractures 61 hepatorenal syndrome 61 ICD implantation 61 hematologic toxicity 61 hemodynamically significant 61 intracranial hemorrhage ICH 61 metabolic parameters 61 urolithiasis 61 underwent resection 61 ADHF 61 comorbid anxiety 61 unmeasured confounders 61 detrusor overactivity 61 postprocedure 61 pretest probability 61 arterial thromboembolic events 61 cranial irradiation 61 suicide attempters 61 preintervention 61 hypovolemia 61 reflux symptoms 61 chronic renal disease 61 calcaneal fractures 61 conventional angiography 61 hallux valgus 61 inflammatory biomarkers 61 CrCl 61 undergoing CABG 61 epidural analgesia 61 angiographic outcomes 61 femoral neck fracture 61 subclinical hyperthyroidism 61 neuropsychological impairments 61 periprocedural MI 61 NATRECOR R 61 euthymic patients 61 multivessel disease 61 voiding dysfunction 61 symptomatic hyponatremia 61 juvenile idiopathic arthritis 61 ELBW infants 61 adrenalectomy 61 % CI #.#-#.# [008] 61 fibroids endometriosis 61 testosterone supplementation 61 posttreatment 61 nodal metastases 61 carotid plaque 61 acute coronary syndromes 61 affective disorder 61 multivariate logistic regression 61 atherothrombotic disease 61 RLS symptoms 61 affective psychosis 61 definite stent thrombosis 61 psychosocial functioning 61 affective disorders 61 decompensated heart failure 61 nulliparous women 61 salmeterol HFA MDI 61 proliferative diabetic retinopathy 60 decompensated cirrhosis 60 macrovascular complications 60 severe exacerbations 60 patients undergoing CABG 60 univariate analyzes 60 systemic corticosteroids 60 nonpsychiatric 60 platelet reactivity 60 neuroleptics 60 angioplasty stenting 60 adjuvant therapies 60 hyperkalemia 60 euthymic 60 univariate analysis 60 unmeasured factors 60 VTE prophylaxis 60 nonoperative 60 prescribed opioids 60 untreated OSA 60 APOE genotype 60 androgen suppression 60 cerebral infarction 60 vWD 60 TAVR 60 hematopoietic cancers 60 systemic corticosteroid 60 bacterial prostatitis 60 atypical antipsychotic medications 60 Testosterone deficiency 60 laboratory abnormalities 60 aortic insufficiency 60 MACCE 60 VLBW 60 reoperations 60 neurologic abnormalities 60 stenoses 60 sotalol 60 recurrent atrial fibrillation 60 VTEs 60 multivariable analysis 60 SLNB 60 mortality morbidity 60 CI #.#-#.# [001] 60 postoperative complications 60 CHD mortality 60 postoperative pulmonary 60 unstable angina UA 60 anticholinergic medications 60 hemodialysis patients 60 PASI scores 60 bivariate analyzes 60 intima media thickness 60 hypercoagulable 60 systolic dysfunction 60 TMP SMX 60 IOP lowering 60 androgen excess 60 potential confounding variables 60 premorbid 60 APTIVUS r 60 unfavorable prognostic 60 angiographically 60 neurocognitive function 60 Postoperative complications 60 dysfunctional voiding 60 macroalbuminuria 60 ICD shocks 60 estimated GFR 60 QT interval prolongation 60 microscopic hematuria 60 procedural sedation 60 leiomyomas 60 prostate TURP 60 polypharmacy 60 abnormal lipid 60 spirometric 60 juvenile idiopathic arthritis JIA 60 elevated triglyceride levels 60 nonischemic 60 myopathy rhabdomyolysis 60 Comorbidity 60 vertebral fracture 60 CORE OM 60 Sociodemographic 60 ischemic cardiomyopathy 60 primary hyperparathyroidism 60 advanced adenomas 60 MS DRGs 60 colorectal adenoma 60 myocardial infarctions 60 Infusion Reactions Severe 60 Prehypertension 60 Exacerbations 60 cardioembolic stroke 60 oral antidiabetes 60 Preoperatively 60 Multivariate analyzes 60 dopaminergic therapy 60 risperidone Risperdal 60 pheochromocytoma 60 antiplatelet drugs 60 immunosuppressive agents 60 intracranial stenosis 60 gallstone disease 60 FFR measurements 60 del 5q MDS 60 SGRQ 60 % CI #.#-#.# [005] 60 vesicoureteral reflux 60 thyroid nodules 60 renal tumors 60 neurologic impairment 60 pelvic lymphadenectomy 60 serum aminotransferase levels 60 isolated systolic hypertension 60 unfavorable cytogenetics 60 corticosteroid therapy 60 BRCA1 mutation carriers 60 HPA axis suppression 60 revascularization procedure 60 radiotherapy RT 60 nephron sparing surgery 60 NPH insulin 60 coronary stenoses 60 Depressive symptoms 60 hypersomnia 60 Baseline characteristics 60 cerebrovascular events 60 psychosocial variables 60 preoperative chemotherapy 60 cytogenetic abnormalities 60 de ath 60 malignant neoplasm 60 MADRS score 60 thoracoscopic lobectomy 60 transurethral resection 60 lumbar disk herniation 60 BMI z 60 coinfected patients 60 proton MR spectroscopy 60 hypopituitarism 60 oral antidiabetic medication 60 revascularizations 60 hypercalciuria 60 antithrombotics 60 nonfasting triglyceride levels 60 gastrointestinal GI bleeding 60 endometriosis ovarian cysts 60 inotropic 60 elevated serum creatinine 60 guideline concordant 60 cryptogenic stroke 60 GH deficiency 60 microvascular complications 60 logistic regression analysis 59 polyarticular 59 Radical prostatectomy 59 proliferative retinopathy 59 infarctions 59 tumor necrosis 59 potentially modifiable 59 reinfarction 59 underwent CABG 59 arteriography 59 generalized seizures 59 echocardiographic parameters 59 adnexal mass 59 vasomotor symptoms 59 hyperprolactinemia 59 Secondary efficacy endpoints 59 QTc prolongation 59 antithrombotic therapy 59 lymph node involvement 59 pre operatively 59 antiplatelet agents 59 diagnostic workup 59 neurologic symptoms 59 myocardial ischemia 59 inhaled glucocorticoids 59 relapsed SCLC 59 diabetes dyslipidemia 59 BMI ≥ 59 onset diabetes mellitus 59 rebleeding 59 coagulopathy 59 unipolar depression 59 concomitant AEDs 59 prespecified secondary 59 antioxidant supplementation 59 hypocalcemia 59 pharmacological approaches 59 chronic prostatitis chronic 59 posttransplant 59 HF hospitalization 59 chronic renal insufficiency 59 preoperative 59 HeFH 59 diabetes mellitus DM 59 contrast induced nephropathy 59 nonfatal myocardial infarction MI 59 pharmacological therapies 59 predisposing factor 59 hypovitaminosis D 59 elevated CRP 59 prednisone prednisolone 59 logistic regression models 59 paclitaxel eluting stents 59 cytopenias 59 urinary incontinence UI 59 subclinical disease 59 recurrent venous thromboembolism 59 asthma exacerbation 59 inhospital 59 fluid overload 59 systolic BP 59 catheter angiography 59 cognitively intact 59 LTBI 59 percutaneous interventions 59 lipid abnormalities 59 symptomatic VTE 59 Meta analyzes 59 confounder 59 prognostic indicators 59 SCr 59 QTc intervals 59 hemoglobin A1c levels 59 citalopram Celexa 59 recurrent VTE 59 aortic regurgitation 59 pharmacodynamic parameters 59 surrogate markers 59 lacunar 59 nonalcoholic steatohepatitis 59 chronic metabolic acidosis 59 gestational diabetes mellitus 59 asymptomatic PAD 59 sonographic diagnosis 59 nodal metastasis 59 glitazones 59 HSCT 59 Hurthle cell 59 myocardial infarction stroke 59 angina myocardial infarction 59 induce orthostatic hypotension 59 CTEPH 59 perioperatively 59 neurodevelopmental outcomes 59 endoscopic ultrasonography 59 femoral neck fractures 59 chorioamnionitis 59 antihypertensive agents 59 nonobese 59 thiopurine 59 corticosteroid dose 59 A1c levels 59 SRBD 59 hypoperfusion 59 adrenal suppression 59 diastolic pressures 59 cardiovascular disease hypertension 59 diabetes mellitus 59 dyslipidemias 59 opioid overdose 59 VIIBRYD 59 pulmonary exacerbations 59 familial clustering 59 pharmacologic intervention 59 etiologic 59 NMIBC 59 polyp recurrence 59 Univariate analysis 59 coronary calcification 59 reperfusion therapy 59 undergoing coronary angiography 59 nonrandomized 59 familial aggregation 59 immunosuppressive medications 59 congenital malformations 59 endometrial carcinoma 59 neuropathic 59 loop diuretic 59 uncontrolled seizures 59 geriatric syndromes 59 hypercholesterolaemia 59 cardiometabolic risk 59 thrombocytosis 59 incidentalomas 59 Charlson Comorbidity Index 59 antipsychotic prescribing 59 amenorrhea 59 symptom severity 59 VADT 59 NSTEMI 59 oral antidiabetic drugs 59 % CI #.#-#.# [004] 59 radiographic findings 59 myopia nearsightedness 59 myocardial fibrosis 59 upper airway obstruction 59 postoperative radiotherapy 59 MS DRG 59 clinically meaningful reductions 59 hypertensives 59 genotypic resistance 59 DMARDS 59 acute coronary syndromes ACS 59 sonographic findings 59 residual confounding 59 unstable angina pectoris 59 mixed hyperlipidemia 59 Polypharmacy 59 antiepileptics 59 liver transplant recipients 59 depressive symptoms 59 acute myocardial infarction MI 59 electrolyte abnormalities 59 VUR 59 mammographically 59 malabsorptive 59 pCR 59 antithrombotic therapies 59 COPD exacerbations 59 antihypertensive drugs 59 bosentan 59 dysglycemia 59 prolonged QT intervals 59 HbA 1C 59 exploratory endpoints 59 pharmacological interventions 59 obese adolescents 59 ruptured aneurysms 59 treat NNT 59 extracolonic findings 59 aminotransferases 59 Major Depressive Disorder 59 preterm deliveries 59 dyspareunia 59 lipid lowering drugs 59 gastrointestinal bleeds 59 antenatal depression 59 nociceptive pain 59 angiotensin converting enzyme inhibitors 59 antihypertensive medication 59 neurodevelopmental outcome 59 EQ 5D 59 Suicidal ideation 59 dysthymia 59 EXJADE 59 meta regression 59 myocardial infarction MI 59 thrombotic events 59 antiangiogenic therapy 59 prospectively defined 59 hamartomas 59 surgical revascularization 59 Myocardial infarction 59 breast abscesses 59 percutaneous intervention 59 DVT PE 59 secondary efficacy endpoint 59 neurocognitive functioning 59 recurrent DVT 59 vaginal hysterectomy 59 Coronary Artery Bypass Graft 59 EBRT 59 Vitamin B# deficiency 59 postintervention 58 neurologic dysfunction 58 subsyndromal 58 potassium sparing diuretics 58 anemia neutropenia 58 intracranial hypertension 58 perinatal outcomes 58 acute myocardial infarction AMI 58 Stent thrombosis 58 estimated glomerular filtration 58 intravenous bisphosphonates 58 PSADT 58 invasive coronary angiography 58 pharmacologic therapies 58 coagulation abnormalities 58 deep venous thromboses 58 defibrillator implantation 58 serum PTH 58 HER2 overexpression 58 rFVIIa 58 syncopal episodes 58 antimuscarinic 58 spinal metastases 58 progressive dyspnea 58 Hyperlipidemia 58 baseline FEV 58 symptomatology 58 hip BMD 58 cerebrovascular accident 58 pericardial effusion 58 lipohypertrophy 58 onset seizures 58 daytime somnolence 58 decrements 58 elevated ALT 58 WARNINGS Myopathy Rhabdomyolysis 58 Uncontrolled hypertension 58 perfusion abnormalities 58 ALND 58 conventional antipsychotics 58 levodopa therapy 58 symptomatic fibroids 58 salmeterol fluticasone 58 serum IGF 58 venous reflux 58 secondary efficacy endpoints 58 APTIVUS ritonavir 58 baseline HbA1c 58 MGUS 58 antihypertensive therapy 58 epididymitis 58 psychotherapeutic interventions 58 severe hypoglycaemia 58 decompensation 58 myeloproliferative neoplasms 58 inpatient hospitalization 58 extrapyramidal symptoms EPS 58 etiologies 58 fibrinolytic therapy 58 psychiatric diagnoses 58 Thiazolidinediones 58 HBeAg positive patients 58 biochemical abnormalities 58 EuroSCORE 58 cardiac malformations 58 indicates cardio circulatory 58 thymectomy 58 newer atypical antipsychotics 58 hemodynamic parameters 58 F FDG PET 58 ATACAND 58 dosage regimens 58 cTnT 58 elevated triglycerides 58 lipid lowering therapies 58 poststroke depression 58 artery stenosis 58 acetabular fracture 58 PLMs 58 Postoperative 58 rheumatologic 58 conditional logistic regression 58 occlusive disease 58 aripiprazole 58 atypical hyperplasia 58 nicardipine 58 antiplatelet therapies 58 lowest tertile 58 virological response 58 parathyroidectomy 58 prenatally diagnosed 58 fluoxetine paroxetine 58 inhaled corticosteroid therapy 58 antiepileptic drugs AEDs 58 postoperative chemotherapy 58 fetal malformations 58 dose atorvastatin 58 FDG PET 58 metabolic disturbances 58 #q# deletion syndrome 58 Cognitive Impairment 58 Secondary endpoints 58 NYHA class 58 hypoglycaemic episodes 58 neuropsychological functioning 58 nephrotoxicity 58 antiemetics 58 immunocompromised individuals 58 antiarrhythmic medications 58 somatoform disorder 58 confounding factors 58 nasal obstruction 58 certolizumab 58 liver metastasis 58 oxycodone CR 58 uncontrolled hypertension 58 BENICAR HCT 58 malperfusion 58 hypertension dyslipidemia 58 hepatic insufficiency 58 parous women 58 asplenia 58 multivariable adjusted 58 nonpsychotic 58 internalizing disorders 58 Asymptomatic 58 primary dysmenorrhoea 58 cytomegalovirus infection 58 echocardiographic 58 coronary blockages 58 pulmonary resection 58 multivariate Cox 58 carotid artery stenting CAS 58 Glucocorticoids 58 Nocturia 58 ventricular dysfunction 58 pyridostigmine 58 ADEs 58 menopausal symptom 58 MDRD equation 58 Mood disorders 58 obstructive coronary artery 58 adenomatous 58 vascular dysfunction 58 chronic noncancer pain 58 obstetric interventions 58 mitochondrial toxicity 58 prolactin levels 58 postmenopausal hormone 58 depressive symptom 58 osteopenic 58 Fluid retention 58 perinatal complications 58 tonsillar hypertrophy 58 elective PCI 58 aldosterone antagonists 58 Primary IGFD 58 sonographic examinations 58 anticholinergics 58 TURBT 58 anticoagulant therapy 58 tracheal intubation 58 lipid elevations 58 refractory ischemia 58 endometrial hyperplasia 58 sleep apneas 58 osteochondroma 58 asymptomatic carotid stenosis 58 metabolic dysregulation 58 visceral metastases 58 Acute Coronary Syndromes 58 DMARD 58 repeat revascularization 58 syncopal episode 58 carotid atherosclerosis 58 empyema 58 somatic complaints 58 albuminuria 58 glycoprotein IIb IIIa inhibitors 58 diabetes mellitus hypertension 58 elevated creatinine 58 HER2 expression 58 invasive candidiasis 58 carotid bruit 58 central corneal thickness 58 carotid artery stenosis 58 radical nephrectomy 58 adjunctive ABILIFY 58 silent ischemia 58 advanced adenoma 58 bezafibrate 58 LVNC 58 subscore 58 transvaginal sonography 58 NOMID 58 intact parathyroid hormone 58 fragility fractures 58 Preoperative 58 familial predisposition 58 menstrual irregularity 58 relapsed AML 58 pulmonary embolism PE 58 coronary lesions 58 androgen ablation 58 atrial arrhythmias 58 hypochondriasis 58 supratentorial 58 endometrial thickness 58 postsurgical 58 Hypotension 58 impaired glucose metabolism 58 Aspergillus infections 58 neurological sequelae 58 intravesical therapy 58 syncope 58 moderate renal impairment 58 nephrolithiasis 58 tapentadol ER 58 % CI #.#-#.# [007] 58 HRCT 58 preoperative evaluation 58 polypoid lesions 58 tamsulosin 58 lactic acidosis 58 baseline LDH 58 psoriatic arthritis PsA 58 vestibular dysfunction 58 colorectal neoplasia 58 pyelonephritis 58 hypoparathyroidism 58 ischemic lesions 58 oral antidiabetes drugs 58 antiarrhythmic drugs 58 thyroid carcinoma 58 morbidity 58 multifactorial 58 EGFR mutation status 58 RYGB 58 hypercholesterolemia 57 Scale EDSS score 57 elevated fasting glucose 57 nephropathy 57 syncopal 57 topical NSAIDs 57 thrombolytic therapy 57 Nesiritide 57 hyperlipidemia hypertension 57 rheumatoid arthritis osteoarthritis ankylosing 57 teratogenic 57 colorectal liver metastases 57 sleep disordered breathing 57 intraventricular hemorrhage 57 NAMCS 57 Thrombocytopenia 57 SIADH 57 hemodilution 57 pT3 57 breast endometrial 57 incomplete revascularization 57 Renal dysfunction 57 Caesarean deliveries 57 PSA nadir 57 Ebstein anomaly 57 calculi 57 preserved ejection fraction 57 LVSD 57 neurosensory 57 debulking surgery 57 pulmonary dysfunction 57 aortic root replacement 57 randomized controlled trials RCTs 57 anastomotic leak 57 Generalized anxiety disorder 57 daytime drowsiness 57 metformin sulfonylurea 57 β blocker 57 liver histology 57 metabolic acidosis 57 QoL 57 Poisson regression 57 symptomatic NOH 57 BPH LUTS 57 inhaled bronchodilators 57 candidemia 57 ALT elevations 57 ofpatients 57 aripiprazole Abilify 57 lethal arrhythmias 57 extramedullary 57 parasomnias 57 NNRTI resistance 57 psychiatric disorders 57 pretransplant 57 G6PD deficiency 57 confidence interval #.#-#.# 57 inhospital mortality 57 psychosocial stressors 57 Knee osteoarthritis 57 serum lipid levels 57 lung resections 57 hemodynamically stable 57 sequelae 57 pancreatectomy 57 pancreatic adenocarcinoma 57 parkinsonian symptoms 57 bone scintigraphy 57 chronic thromboembolic pulmonary 57 pharmacological intervention 57 metformin monotherapy 57 neonatal morbidity 57 perimenopausal women 57 hip resurfacing arthroplasty 57 chronic pancreatitis 57 neuropsychological assessment 57 cytoreductive surgery 57 partial onset seizures 57 Obstructive Sleep Apnea 57 leucopenia 57 congenital anomalies 57 relapsed MM 57 INVEGA ® 57 hemodynamically unstable 57 haloperidol Haldol 57 uncontrolled asthma 57 abnormal lipids

Back to home page